AIHC
SEPTEMBER 5, 2023
Compliance Considerations for Best Outcomes Written in collaboration with the AIHC Volunteer Education Committee Delivering mental health services via telehealth has increased since the COVID-19 pandemic. Higher rates of use of telehealth are now standard in many practices since the coronavirus disease 2019 (COVID-19) pandemic.
AIHC
OCTOBER 11, 2021
Written By: Compliance Blogger This article addresses COVID testing and consent considerations for: healthcare organizations, nursing homes and business associates or non-healthcare workplaces. SARS-CoV-2 (COVID-19) continues to be a health risk to be mitigated by health care institutions and at the workplace.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
NOVEMBER 17, 2021
As with countless global industries, clinical trials were forced to move key functions online as COVID-19 swept the world in early 2020. Further underscoring this trend, 93% of sites also reported that they would allow sponsors or CROs to conduct remote monitoring, compared to 74% pre-COVID. Improving Protocol Compliance.
Hall Render
SEPTEMBER 14, 2023
This draft guidance expands on previous FDA recommendations released in the midst of the COVID-19 pandemic. For health care institutions conducting DCTs, considerations include compliance with fraud and abuse and beneficiary inducement requirements.
Verisys
JANUARY 27, 2022
COVID has impacted every aspect of daily life, and these changes have affected people’s mental health, making telehealth services for behavioral health more important than ever. These license verification requirements have continued to change, so keeping up with regulations in telehealth is vital to compliance. According to the U.S.
Healthcare Law Today
DECEMBER 12, 2022
He advises entrepreneurial health care providers and technology companies on business arrangements, compliance, and corporate matters in telemedicine, digital health, remote patient monitoring, and click-and-mortar services. With that in mind, let’s start with you, Mark. Mark Josephs.
SQA
APRIL 30, 2021
Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19 Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19 vaccine exports. The mechanism provides for authorizations of exports of COVID-19 vaccines outside the EU.
Expert insights. Personalized for you.
59 
Let's personalize your content